Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
14

Summary

Conditions
Burns
Type
Interventional
Phase
Phase 2
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 65 years
Gender
Both males and females

Description

This is an open-label, randomized, active-controlled pilot study to evaluate the efficacy and safety profile of topical MW-III versus an active control (Silvadene® Cream 1% [Silver Sulfadiazine]) in the treatment of second-degree thermal burns in adults. Approximately 30 subjects per treatment group...

This is an open-label, randomized, active-controlled pilot study to evaluate the efficacy and safety profile of topical MW-III versus an active control (Silvadene® Cream 1% [Silver Sulfadiazine]) in the treatment of second-degree thermal burns in adults. Approximately 30 subjects per treatment group will be enrolled and 60 subjects in total.

Tracking Information

NCT #
NCT01297400
Collaborators
Not Provided
Investigators
Not Provided